Lexicon Pharmaceuticals Newsroom

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT NewswiresNov 23 04:45

Sector Update: Health Care

MT NewswiresNov 23 04:24

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Futu NewsNov 23 02:31 · Ratings

Needham Reiterates Hold on Lexicon Pharmaceuticals

BenzingaNov 23 02:02

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 23 02:01 · Ratings

HC Wainwright Cuts Price Target on Lexicon Pharmaceuticals to $4 From $6, Maintains Buy Rating

MT NewswiresNov 23 00:45 · Ratings

Lexicon Pharmaceuticals to Cut 60% of Workforce

MT NewswiresNov 22 21:43

Lexicon Falls on Restructuring Program

Seeking AlphaNov 22 21:02

Lexicon Pharmaceuticals Says Company Has Made Strategic Decision To Eliminate Its Commercial Operations And Rationalize Resources Across All Functions In Order To Preserve Cash And Focus Its Resources On Advancing Promising Clinical Development...

BenzingaNov 22 20:36

Express News | Lexicon Pharmaceuticals Inc: Receipt of a "Deficiencies Preclude Discussion" Letter From FDA Regarding Nda for Zynquista

BreakingsNov 22 20:36

Express News | Lexicon Pharmaceuticals Inc: Elimination of Promotional Efforts for Inpefa, Planned Commercial Activities for Zynquista

BreakingsNov 22 20:34

Express News | Lexicon Pharmaceuticals Inc: Total Reduction of Approximately 60 Percent of Employees, Effective for Most Affected Employees by December 31

BreakingsNov 22 20:32

Express News | Lexicon Pharmaceuticals Inc: Implementing Strategic Restructuring to Eliminate Commercial Organization and Rationalize Operations Across All Functions

BreakingsNov 22 20:32

Express News | Lexicon Pharmaceuticals Inc: Prioritizing Strong R&D Pipeline Including Ongoing Studies in Dpnp, HCM and Obesity

BreakingsNov 22 20:32

Express News | Lexicon Pharmaceuticals Inc: Efforts Expected to Reduce 2025 Operating Costs by $100 Mln

BreakingsNov 22 20:32

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA

GlobeNewswireNov 22 20:32

Express News | Lexicon Appoints Ivan H. Cheung to Board of Directors

BreakingsNov 21 05:05

Press Release: Lexicon Appoints Ivan H. Cheung to Board of Directors

Dow JonesNov 21 05:05

Lexicon Pharmaceuticals (NASDAQ:LXRX Investor Three-year Losses Grow to 80% as the Stock Sheds US$107m This Past Week

Yahoo FinanceNov 18 21:07

Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations Is Among Four Lexicon-Supported Presentations at the American Heart Association's (AHA) Sessions 2024 in Chicago

GlobeNewswireNov 14 21:00